The Allstate Corporation (ALL) Stock Price & Analysis

The Allstate Corporation (ALL) closed at USD 255.92 on Thursday, October 29, 2026, up 2.29% on the day. The US market is currently closed (after-hours); this is not a live price.

The prior close was USD 250.2; the Oct 29, 2026 session ranged USD 252–256.83 on volume of 1,216,153 shares. Market capitalization is $64.71B, with a 52-week range of USD 188.15–277.22 (NYQ). Source: Nexqual, retrieved October 29, 2026 at 21:34 UTC.

Also available as compact Markdown for AI agents: nexqual.com/ALL.md

Key facts (ALL)

• Last four reported quarters (through Jun 30, 2026): revenue $70.1B, net income $13.3B (18.9% margin), free cash flow $12.2B (SEC filings).
• Valuation: P/E 4.9x (avg 8.3x at the last 2 fiscal year-ends).
• 3 of 80 tracked superinvestors hold ALL (13F, Q2 2026): 0 new, 1 added, 0 reduced, 2 unchanged.
• Insider open-market sales, last ~7 months: 5 Form 4 filings, $28.6M; 5 not under a Rule 10b5-1 plan ($28.6M); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
• Analysts: Hold (mean 2.72 on a 1–5 scale) (25 analysts), mean target USD 269.27 (range 191–340).
• Total return with dividends: 1Y +36.0% vs S&P 500 +14.4%; 5Y +132.9% vs S&P 500 +79.1%.
• Next earnings: 2026-11-04, EPS estimate USD 6.96, revenue estimate $17.5B.

Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (ALL)

Fiscal years end Dec. EPS is split-adjusted.

Valuation (price ÷ last four quarters, through Jun 30, 2026) (ALL)

P/E 4.9x · P/S 0.9x · P/FCF 5.3x · P/B 1.9x · FCF yield 18.93% · Earnings yield 20.52% · Dividend yield (paid, TTM) 1.65% · Buyback yield (TTM) 3.80%

P/E at fiscal year-ends: Dec 2025 5.4x, Dec 2024 11.1x.

Superinvestors (SEC 13F-HR, Q2 2026) (ALL)

3 of 80 tracked investors hold ALL. Each row is the investor's latest 13F; change is vs their prior-quarter share count.

Insider sales (SEC Form 4, open-market, last ~7 months) (ALL)

0 of 5 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.

% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).

Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.

Analysts (ALL)

Consensus Hold (mean 2.72 on a 1–5 scale), 25 analysts; mean target USD 269.27 (low 191, high 340).

Rating changes, last 120 days:

Total return (dividends reinvested) (ALL)

ALL earnings history and stock reaction

EPS as reported against the analyst consensus before the release; surprise uses the cent-rounded figures shown (in dollars when EPS and consensus have opposite signs). Stock reaction = close before the results to close after (the first close following a release after the bell or before the open).

ALL recent SEC filings (last 120 days)

Source: SEC EDGAR. Quotes are the opening words of each item as filed; each form links to the filing. Insider Form 4 filings are listed in the insider sections.

ALL revenue by business segment (quarter ended Jun 30, 2026)

As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).

Companies that name ALL in their SEC reports

ALL company outlook (results filed Aug 5, 2026)

• “The overall portfolio allocation to performance-based assets provides a diversifying source of attractive long-term returns; quarterly volatility in reported results is expected. ◦ Net gains on investments and derivatives were $1.1 billion in the second quarter of 2026, compared to losses of $144 million in the prior year quarter.”
• “Financial information, including material announcements about The Allstate Corporation, is routinely posted on www.allstateinvestors.com . 5 Exhibit 99.1 Forward-Looking Statements This news release contains "forward-looking statements" that anticipate results based on our estimates, assumptions and plans that are subject to uncertainty.”

Quoted word-for-word from the SEC 8-K results press release.

ALL analyst estimates and revisions

ALL options: expected move

Options price a move of about ±6.7% (±$17.05) by Nov 20, 2026, which includes earnings on Nov 4, 2026. Over the last 8 reports the stock moved ±2.4% on average.

30-day implied volatility 31.5% vs 29.9% realized over the last 30 trading days. Put/call ratio (volume) 0.51. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.

Key Statistics (as of October 29, 2026 at 21:34 UTC)

Technical Analysis (ALL)

Nexqual's technical model rates ALL "BUY" based on 5 bullish and 1 bearish signals across 127 daily candles, as of October 29, 2026 at 21:34 UTC.

Analyst Ratings (ALL)

Wall Street analysts rate ALL "Hold" based on 25 analysts, with a mean price target of USD 269.27 (range USD 191–340), per Nexqual as of October 29, 2026 at 21:34 UTC.

Earnings (ALL)

Recent Earnings History

Source: Nexqual, October 29, 2026 at 21:34 UTC.

Financials & Fundamentals (ALL)

Source: Nexqual, October 29, 2026 at 21:34 UTC.

Financial Health Score (ALL)

Nexqual rates The Allstate Corporation's overall financial health "Solid" across five dimensions, as of October 29, 2026 at 21:34 UTC.

Ownership (ALL)

Source: Nexqual, October 29, 2026 at 21:34 UTC.

Leadership (ALL)

The Allstate Corporation is led by Thomas Joseph Wilson, Chairman of the Board, President & CEO, per Nexqual as of October 29, 2026 at 21:34 UTC.

Major Backers & Investors (ALL)

Notable institutional backers of The Allstate Corporation include Franklin Resources, Inc., Price (T.Rowe) Associates Inc, Bank of America Corporation, according to Nexqual as of October 29, 2026 at 21:34 UTC.

Active Investors

Index Funds (Passive)

Source: Nexqual, October 29, 2026 at 21:34 UTC.

From The Allstate Corporation's Latest SEC 10-K Filing (filed 2026-02-20)

Legal & Regulatory Risks (Item 1A, quoted)

• Regulatory restrictions or potential delays in the regulatory approval process for new products and features or the use of advanced technologies, non-traditional data sources, or large language models may impact our ability to innovate and enhance the competitiveness of our product offerings in the marketplace.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 29, 2026 at 21:34 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt